Serial entrepreneur Jeff Karp has a philosophy for his laboratory: find important problems and get solutions to people quickly. To learn about the exciting technologies emerging from Karp’s lab, join us at DeviceTalks Boston on Oct. 8-10.
After Jeff finished his PhD in chemical and biomedical engineering at the University of Toronto, he knew he wanted to work with Robert Langer.
“He’s the intergalactic translational superstar,” Karp said.
Langer, a professor at the Massachusetts Institute of Technology and one of the most cited engineers of all time, receives thousands of applications per year from people looking to join his lab, Karp said. So when Langer wrote back to Karp telling him that his lab didn’t have enough funding to take him, Karp took matters into his own hands.
“So I wrote him back and said, ‘Well, if I brought my own funding, would you take me?’ and he wrote back immediately and said, ‘Yes,’” Karp told us. “And then I said, ‘Would you put that in writing?’”
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.